Jefferies Financial Group Inc. Buys New Stake in Acadia Healthcare Company, Inc. $ACHC

Jefferies Financial Group Inc. bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,379,813 shares of the company’s stock, valued at approximately $47,960,000. Jefferies Financial Group Inc. owned about 3.66% of Acadia Healthcare at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the business. EverSource Wealth Advisors LLC increased its position in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Bayforest Capital Ltd acquired a new stake in shares of Acadia Healthcare during the fourth quarter worth about $52,000. Hantz Financial Services Inc. increased its position in shares of Acadia Healthcare by 501.9% during the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after purchasing an additional 1,822 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Acadia Healthcare by 124.7% during the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after purchasing an additional 2,698 shares in the last quarter. Finally, Covestor Ltd increased its position in shares of Acadia Healthcare by 36.0% during the third quarter. Covestor Ltd now owns 6,004 shares of the company’s stock worth $149,000 after purchasing an additional 1,589 shares in the last quarter.

Acadia Healthcare Price Performance

ACHC stock opened at $23.18 on Friday. The firm has a 50 day moving average of $25.21 and a 200-day moving average of $19.32. Acadia Healthcare Company, Inc. has a 12-month low of $11.43 and a 12-month high of $30.20. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The company has a market cap of $2.13 billion, a price-to-earnings ratio of -1.89, a PEG ratio of 7.79 and a beta of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. During the same period last year, the firm earned $0.40 EPS. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, equities analysts expect that Acadia Healthcare Company, Inc. will post 1.49 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Jefferies Financial Group reiterated a “hold” rating and set a $24.50 target price on shares of Acadia Healthcare in a research report on Monday, April 20th. Royal Bank Of Canada raised their price target on Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a report on Monday, May 4th. Cantor Fitzgerald raised their price target on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a report on Friday, May 1st. Leerink Partners upped their price objective on Acadia Healthcare from $14.00 to $22.00 and gave the company a “market perform” rating in a research note on Thursday, February 26th. Finally, Barclays upped their price objective on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, April 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $26.04.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.